Episode
B1 French News | Can This New Pill Help Pancreatic Cancer Patients Live Longer?
- Published
- Aug 27, 2026
- Duration seconds
- 552
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/learn-french-b1-with-news-french-listening-practice-7793132/episodes/b1-french-news-can-this-new-pill-help-pancreatic-cancer-patients-live-longer-2/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/learn-french-b1-with-news-french-listening-practice-7793132/b1-french-news-can-this-new-pill-help-pancreatic-cancer-patients-live-longer-2.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Learn French through today’s real news. Natural-pace French at B1, with a full transcript and English translation. In this episode: Medicare's obesity-drug program is taking off, with CVS and Walgreens already filling about 100,000 prescriptions each at $50 a month. Also: The FDA approves daraxonrasib, a daily pill that nearly doubled average survival for pancreatic cancer patients in trials. Aujourd'hui : Medicare attire déjà beaucoup de patients · Un nouveau traitement contre le cancer du pancréas. Today’s French focus: va durer, is going to last = is going to last. Vocabulary: programme (program), prix (price), facture (bill). Learn more from today’s episode with the full podcast transcript, English translation, vocabulary explanations, and extra learning materials: https://linguawire.com/episodes/french-b1-2026-08-27 Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.